Case_id: case_512
Case_description: 
A 35-year-old woman presents to her primary care provider concerned that she may be pregnant. She has a history of regular menstruation every 4 weeks that lasts about 4 days with mild to moderate bleeding, but she missed her last period 2 weeks ago. A home pregnancy test was positive. She has a 6-year history of hyperthyroidism that is well-controlled with daily methimazole. She is currently asymptomatic and has no complaints or concerns. A blood specimen is taken and confirms the diagnosis. Additionally, her thyroid-stimulating hormone (TSH) is 2.0 μU/mL. Which of the following is the next best step in the management of this patient?
Options: 
1. Continue methimazole
2. Discontinue methimazole, start propylthiouracil
3. Add glucocorticoids
4. Add propranolol
5. Refer for radioiodine therapy
Correct Answer: Discontinue methimazole, start propylthiouracil

================================================================================
Launch the MCC process
================================================================================
GPT is reasoning the answer...

GPT's diagnostic conclusion:
Choice: Option 2 (Discontinue methimazole, start propylthiouracil)

GPT's full response:
================================================================================
**1. Case Summary and Key Symptoms**  
- **Basic Information**: A 35-year-old woman with a history of hyperthyroidism controlled with methimazole for six years.  
- **Chief Complaint**: Concern about possible pregnancy due to a missed period two weeks ago.  
- **Key Clinical Manifestations**:  
  - Missed period (amenorrhea) confirmed by a positive home pregnancy test and blood specimen.  
  - Current TSH level is 2.0 μU/mL, indicating well-controlled thyroid function.  
  - Asymptomatic with no additional complaints or concerns.

**2. Analysis of Clinical Features**  
- **Timeline**: The patient has a long-standing history of hyperthyroidism managed with methimazole. The recent missed period and positive pregnancy test indicate a new pregnancy likely in the early first trimester.  
- **Characteristics of Symptoms**: The absence of symptoms suggests that her hyperthyroidism remains controlled despite the pregnancy.  
- **Interrelationships**: The use of methimazole in a pregnant woman raises concerns due to potential teratogenic effects, particularly in the first trimester. The controlled TSH level implies effective management but necessitates evaluation of medication safety during pregnancy.  
- **Diagnostic Support**: Positive pregnancy test alongside history of hyperthyroidism on methimazole strongly suggests the need to reassess her current antithyroid therapy to prevent fetal complications.

**3. Differential Diagnosis Analysis**  
- **Option 1: Continue methimazole**  
  - *Analysis*: Methimazole is associated with congenital anomalies such as aplasia cutis and choanal/esophageal atresia when used in the first trimester. Current guidelines recommend avoiding methimazole during early pregnancy if possible.  
- **Option 2: Discontinue methimazole, start propylthiouracil**  
  - *Analysis*: Propylthiouracil (PTU) is preferred during the first trimester due to a lower risk of teratogenic effects compared to methimazole. This aligns with clinical guidelines for managing hyperthyroidism in pregnant patients. PTU has its own risks, such as hepatotoxicity, but these are managed by discontinuing PTU after the first trimester and possibly reverting to methimazole.  
- **Option 3: Add glucocorticoids**  
  - *Analysis*: Glucocorticoids are not indicated in this scenario as there is no evidence of adrenal insufficiency or another condition requiring their use.  
- **Option 4: Add propranolol**  
  - *Analysis*: Propranolol is used to manage symptoms of hyperthyroidism such as tremors and tachycardia. However, the patient is currently asymptomatic, making this option unnecessary.  
- **Option 5: Refer for radioiodine therapy**  
  - *Analysis*: Radioiodine therapy is contraindicated in pregnancy as it can destroy fetal thyroid gland and lead to fetal hypothyroidism. Immediate cessation is required if pregnancy is confirmed, making this option inappropriate.

**4. Final Selection**  
**My final selection is: Option 2 (Discontinue methimazole, start propylthiouracil)(停止甲硫咪唑，开始使用丙硫氧嘧啶)**
================================================================================
Qwen is reasoning the answer...

Qwen's diagnostic conclusion:
Choice: Option 2 (Discontinue methimazole, start propylthiouracil)

Qwen's full response:
================================================================================
**1. Case Summary and Key Symptoms**  
- A 35-year-old woman presents with a missed menstrual period of 2 weeks and a positive home pregnancy test. She has a history of well-controlled hyperthyroidism managed with methimazole. Blood tests confirm pregnancy. Thyroid-stimulating hormone (TSH) is 2.0 μU/mL (within the normal range).  
- Key symptoms: Missed period, positive pregnancy test, and history of hyperthyroidism.  
- Decisive features: Confirmed pregnancy and ongoing methimazole use require immediate adjustment of thyroid medication due to pregnancy-related safety concerns.  

---

**2. Analysis of Clinical Features**  
- **Pregnancy confirmation**: The patient’s missed period and positive blood test confirm pregnancy, which necessitates re-evaluation of her current thyroid medication.  
- **Hyperthyroidism control**: Her TSH is normal (2.0 μU/mL), indicating adequate methimazole dosing. However, methimazole is associated with a rare but serious risk of fetal defects (e.g., aplasia cutis, choanal atresia) during pregnancy, particularly in the first trimester.  
- **Asymptomatic status**: The patient has no symptoms, so immediate intervention for hyperthyroidism is not required, but medication adjustment is critical for fetal safety.  

---

**3. Differential Diagnosis Analysis**  
- **Option 1 (Continue methimazole)**:  
  - **Rationale Against**: Methimazole is associated with teratogenic risks in pregnancy, especially in the first trimester. Guidelines recommend switching to propylthiouracil (PTU) during pregnancy due to its safer profile in early pregnancy.  
- **Option 2 (Discontinue methimazole, start PTU)**:  
  - **Rationale For**: PTU is preferred in pregnancy, particularly in the first trimester, as it crosses the placenta less than methimazole and has a lower teratogenic risk. This aligns with American Thyroid Association (ATA) guidelines.  
- **Option 3 (Add glucocorticoids)**:  
  - **Rationale Against**: Glucocorticoids are used for thyroid storm or severe Graves’ orbitopathy, not routine management of pregnancy with hyperthyroidism.  
- **Option 4 (Add propranolol)**:  
  - **Rationale Against**: Propranolol is a beta-blocker for symptom control (e.g., tachycardia), but the patient is asymptomatic. Beta-blockers are not required unless symptoms develop.  
- **Option 5 (Refer for radioiodine therapy)**:  
  - **Rationale Against**: Radioiodine is contraindicated in pregnancy due to risks of fetal thyroid damage and radiation exposure.  

---

**4. Final Selection**  
**My final selection is: Option 2 (Discontinue methimazole, start propylthiouracil)(停用甲巯咪唑，开始丙硫氧嘧啶)**  

**Key evidence supporting this choice**:  
- Methimazole carries a small but significant teratogenic risk in early pregnancy.  
- PTU is the preferred antithyroid drug during pregnancy, especially in the first trimester, due to its lower placental transfer and reduced fetal risk.  
- The ATA guidelines recommend switching to PTU upon confirmation of pregnancy in women on methimazole.  
- The patient’s TSH is within the normal range, indicating that dose adjustments (rather than adding other medications) are sufficient.
================================================================================
DeepSeek is reasoning the answer...

DeepSeek's diagnostic conclusion:
Choice: Option 2 (Discontinue methimazole, start propylthiouracil)

DeepSeek's full response:
================================================================================
**1. Case Summary and Key Symptoms**  
- **Basic Information**: 35-year-old woman with a 6-year history of hyperthyroidism, well-controlled on methimazole.  
- **Chief Complaint**: Missed period (2 weeks ago), positive home pregnancy test confirmed by blood testing.  
- **Key Clinical Manifestations**: Asymptomatic, TSH 2.0 μU/mL (within normal range).  

**2. Analysis of Clinical Features**  
- **Timeline**: Regular menstrual cycles (4-week intervals) with recent missed period and confirmed pregnancy. Methimazole use predates pregnancy.  
- **Thyroid Status**: Stable hyperthyroidism (TSH 2.0 μU/mL indicates euthyroidism under treatment).  
- **Critical Considerations**: Methimazole is teratogenic in the first trimester, increasing risks of congenital anomalies (e.g., aplasia cutis, choanal atresia). Propylthiouracil (PTU) is preferred in early pregnancy due to lower teratogenic risk.  

**3. Differential Diagnosis Analysis**  
1. **Continue methimazole**: Contraindicated in the first trimester due to teratogenicity.  
2. **Discontinue methimazole, start PTU**: Aligns with guidelines for managing hyperthyroidism in pregnancy (PTU preferred in first trimester).  
3. **Add glucocorticoids**: Unnecessary; no evidence of thyroid storm or autoimmune adrenal insufficiency.  
4. **Add propranolol**: Not indicated; patient is asymptomatic with no thyrotoxic symptoms.  
5. **Refer for radioiodine therapy**: Contraindicated in pregnancy (risk of fetal thyroid destruction).  

**4. Final Selection**  
**My final selection is: Option 2 (Discontinue methimazole, start propylthiouracil)(停用甲巯咪唑，改用丙硫氧嘧啶)**  
- **Key Evidence**: Methimazole is teratogenic in the first trimester, while PTU is the recommended antithyroid drug during this period. The patient’s euthyroid state (TSH 2.0 μU/mL) supports safe transition to PTU to minimize fetal risk. Guidelines from the American Thyroid Association (ATA) and Endocrine Society endorse this approach.
================================================================================

The three models have reached an initial consensus!
Correct Answer: Option 2 (Discontinue methimazole, start propylthiouracil)

GPT's initial diagnosis is correct
Qwen's initial diagnosis is correct
DeepSeek's initial diagnosis is correct

The three models have reached an initial consensus!All models selected Option2

========= Final Debate Result =========
GPT, Qwen, and DeepSeek-R1 have reached a consensus!
Final diagnosis: Option2 - Discontinue methimazole, start propylthiouracil
Correct Answer: - Discontinue methimazole, start propylthiouracil

Is the final diagnosis correct? ✓ Correct

